ArticleCancers2023
Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma.
Julian A Marin-Acevedo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
ArticleCancers2023
Julian A Marin-Acevedo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.